CNY 29.90
+5.10%Year over year
Reported trailing growth
- Revenue
- +14.4%
- EBITDA
- —
- EBIT
- +123.9%
- EPS
- +116.0%
- Free cash flow
- +219.3%
- Operating cash flow
- -8.4%
Forward estimates
Based on analyst estimates
- Revenue
- +25.9%
- EBITDA
- +206.5%
- EPS
- +93.4%
Three-year CAGR
- Revenue
- +8.0%
- EBITDA
- -12.4%
- EBIT
- -34.2%
- Net income
- -35.3%
- EPS
- -35.9%
- Free cash flow
- +146.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026